Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/22214
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2021-10-04T08:40:24Z | - |
dc.date.available | 2021-10-04T08:40:24Z | - |
dc.date.issued | 1997 | - |
dc.identifier.citation | Egeli, U. ve Tunca, B. (1997). "Detection of fragile sites induced by pyrimethamine". Teratogenesis Carcinogenesis and Mutagenesis, 17(2), 59-69. | en_US |
dc.identifier.issn | 0270-3211 | - |
dc.identifier.uri | https://doi.org/10.1002/(SICI)1520-6866(1997)17:2<59::AID-TCM2>3.0.CO;2-D | - |
dc.identifier.uri | https://onlinelibrary.wiley.com/doi/10.1002/(SICI)1520-6866(1997)17:2%3C59::AID-TCM2%3E3.0.CO;2-D | - |
dc.identifier.uri | http://hdl.handle.net/11452/22214 | - |
dc.description.abstract | In this study, the effect of pyrimethamine in inducing expression of fragile sites in human peripheral blood lymphocyte cultures is investigated. In vitro lymphocyte cultures of 15 healthy individuals were treated with 0.02 mg/ml of pyrimethamine for 48 and 72 hr. One culture was used as control. The number of cells showing chromosomal aberration increases significantly in the cultures after 48 and 72 hr in comparison to the control group (P < 0.001). Localization of fragile sites was determined by the G-banding method and light microscopy. As a result, five folic acid-sensitive fragile sites (lp32, lq32. 3p14, 6p22, 14q24) were detected. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Oncology | en_US |
dc.subject | Genetics & heredity | en_US |
dc.subject | Toxicology | en_US |
dc.subject | Pyrimethamine | en_US |
dc.subject | Fragile site | en_US |
dc.subject | Lymphocyte culture | en_US |
dc.subject | Chromosomal aberrations | en_US |
dc.subject | G-banding | en_US |
dc.subject | Human-chromosomes | en_US |
dc.subject | Dihydrofolate-reductase | en_US |
dc.subject | Cancer | en_US |
dc.subject | Methotrexate | en_US |
dc.subject | Expression | en_US |
dc.subject | Rearrangements | en_US |
dc.subject | Aberrations | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Antimalarials | en_US |
dc.subject.mesh | Cell culture techniques | en_US |
dc.subject.mesh | Chromosome aberrations | en_US |
dc.subject.mesh | Chromosome banding | en_US |
dc.subject.mesh | Chromosome fragile sites | en_US |
dc.subject.mesh | Chromosome fragility | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Karyotyping | en_US |
dc.subject.mesh | Lymphocytes | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Pyrimethamine | en_US |
dc.title | Detection of fragile sites induced by pyrimethamine | en_US |
dc.type | Article | en_US |
dc.identifier.wos | A1997XN84000002 | tr_TR |
dc.identifier.scopus | 2-s2.0-0030811917 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Biyoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Fen Edebiyat Fakültesi/Moleküler Biyoloji Bölümü. | tr_TR |
dc.contributor.orcid | 0000-0002-1619-6680 | tr_TR |
dc.identifier.startpage | 59 | tr_TR |
dc.identifier.endpage | 69 | tr_TR |
dc.identifier.volume | 17 | tr_TR |
dc.identifier.issue | 2 | tr_TR |
dc.relation.journal | Teratogenesis Carcinogenesis and Mutagenesis | en_US |
dc.contributor.buuauthor | Egeli, Ünal | - |
dc.contributor.buuauthor | Tunca, Berrin | - |
dc.contributor.researcherid | ABI-6078-2020 | tr_TR |
dc.identifier.pubmed | 9261920 | tr_TR |
dc.subject.wos | Oncology | en_US |
dc.subject.wos | Genetics & heredity | en_US |
dc.subject.wos | Toxicology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | Pubmed | en_US |
dc.wos.quartile | Q4 | en_US |
dc.contributor.scopusid | 55665145000 | tr_TR |
dc.contributor.scopusid | 6602965754 | tr_TR |
dc.subject.scopus | Hyperpigmentation; Vitamin B 12 Deficiency; Megaloblastic Anemia | en_US |
dc.subject.emtree | Pyrimethamine | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Chromosome aberration | en_US |
dc.subject.emtree | Chromosome fragile site | tr_TRen_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Genotoxicity | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Human cell | en_US |
dc.subject.emtree | Lymphocyte culture | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Priority journal | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.